🔗 Share this article

The top legal official in Texas Paxton is suing the manufacturers of acetaminophen, claiming the corporations concealed potential risks that the medication created to children's neurological development.

The court filing arrives thirty days after President Donald Trump publicized an unproven link between taking Tylenol - also known as paracetamol - throughout gestation and autism in offspring.

Paxton is filing suit against J&J, which formerly manufactured the medication, the sole analgesic approved for expectant mothers, and the current manufacturer, which presently makes it.

In a declaration, he claimed they "misled consumers by gaining financially from pain and promoting medication ignoring the risks."

The manufacturer says there is insufficient reliable data tying Tylenol to autism spectrum disorder.

"These companies deceived for years, knowingly endangering millions to boost earnings," Paxton, a Republican, declared.

Kenvue said in a statement that it was "deeply concerned by the perpetuation of misinformation on the reliability of acetaminophen and the possible consequences that could have on the welfare of US mothers and children."

On its website, the company also mentioned it had "regularly reviewed the applicable studies and there is insufficient valid information that shows a verified association between using acetaminophen and autism spectrum disorder."

Organizations speaking for doctors and medical practitioners agree.

The American College of Obstetricians and Gynecologists has stated paracetamol - the primary component in acetaminophen - is one of the few options for pregnant women to manage discomfort and elevated temperature, which can create major wellness concerns if ignored.

"In more than two decades of research on the use of acetaminophen in pregnancy, zero credible investigations has conclusively proven that the use of paracetamol in any period of pregnancy causes neurodevelopmental disorders in offspring," the organization commented.

The lawsuit cites current declarations from the former administration in claiming the drug is reportedly hazardous.

Last month, the former president generated worry from medical authorities when he instructed pregnant women to "fight like hell" not to use Tylenol when sick.

The US Food and Drug Administration then released a statement that medical professionals should consider limiting the use of Tylenol, while also mentioning that "a proven link" between the drug and autism spectrum disorder in minors has not been proven.

The Health Department head Robert F Kennedy Jr, who manages the FDA, had pledged in April to conduct "a massive testing and research effort" that would determine the cause of autism spectrum disorder in a matter of months.

But authorities advised that discovering a unique factor of autism - considered by experts to be the consequence of a complicated interplay of genetic and external influences - would be difficult.

Autism spectrum disorder is a type of enduring cognitive variation and condition that impacts how individuals perceive and interact with the environment, and is diagnosed using medical professional evaluations.

In his court filing, the attorney general - who supports Trump who is running for the Senate - alleges the manufacturer and Johnson & Johnson "intentionally overlooked and attempted to silence the evidence" around paracetamol and autism spectrum disorder.

This legal action seeks to make the companies "remove any promotional materials" that claims Tylenol is secure for women during pregnancy.

The Texas lawsuit echoes the grievances of a collection of guardians of children with autism spectrum disorder and attention deficit hyperactivity disorder who filed suit against the makers of Tylenol in 2022.

A federal judge threw out the case, declaring studies from the family's specialists was inconclusive.